XML 18 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Segment Reporting Information) (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
segment
Sep. 30, 2011
Segment Reporting [Abstract]        
Reportable segments (in number of segments)     5  
Revenues:        
Total Revenues $ 388,283,000 $ 162,370,000 $ 838,046,000 $ 435,491,000
Gross Profit:        
Total Gross Profit 119,039,000 54,528,000 263,041,000 146,476,000
Operating Income (Loss):        
Total Operating Income 36,496,000 13,736,000 66,097,000 30,930,000
Apex
       
Segment Reporting Information        
Acquisition costs expensed 700,000   9,400,000  
Revenues:        
Total Revenues 202,664,000 0 301,167,000 0
Gross Profit:        
Total Gross Profit 56,934,000 0 83,917,000 0
Operating Income (Loss):        
Total Operating Income 16,563,000 [1] 0 [1] 14,594,000 [1] 0 [1]
Oxford
       
Revenues:        
Total Revenues 88,104,000 70,074,000 254,970,000 195,512,000
Gross Profit:        
Total Gross Profit 31,250,000 25,113,000 90,266,000 69,483,000
Operating Income (Loss):        
Total Operating Income 13,251,000 9,038,000 36,007,000 23,014,000
Life Sciences
       
Revenues:        
Total Revenues 40,646,000 41,820,000 122,506,000 114,403,000
Gross Profit:        
Total Gross Profit 14,002,000 14,163,000 41,649,000 39,025,000
Operating Income (Loss):        
Total Operating Income 3,020,000 3,026,000 8,291,000 7,378,000
Healthcare
       
Revenues:        
Total Revenues 29,390,000 27,091,000 82,796,000 68,671,000
Gross Profit:        
Total Gross Profit 8,483,000 7,458,000 23,622,000 19,242,000
Operating Income (Loss):        
Total Operating Income 455,000 (522,000) 936,000 (3,423,000)
Physician
       
Revenues:        
Total Revenues 27,479,000 23,385,000 76,607,000 56,905,000
Gross Profit:        
Total Gross Profit 8,370,000 7,794,000 23,587,000 18,726,000
Operating Income (Loss):        
Total Operating Income $ 3,207,000 $ 2,194,000 $ 6,269,000 $ 3,961,000
[1] Three Months Ended Nine Months Ended September 30, September 30, 2012 2011 2012 2011Revenues: Apex$202,664 $— $301,167 $—Oxford88,104 70,074 254,970 195,512Life Sciences40,646 41,820 122,506 114,403Healthcare29,390 27,091 82,796 68,671Physician27,479 23,385 76,607 56,905 $388,283 $162,370 $838,046 $435,491Gross Profit: Apex$56,934 $— $83,917 $—Oxford31,250 25,113 90,266 69,483Life Sciences14,002 14,163 41,649 39,025Healthcare8,483 7,458 23,622 19,242Physician8,370 7,794 23,587 18,726 $119,039 $54,528 $263,041 $146,476Operating Income: Apex (1)$16,563 $— $14,594 $—Oxford13,251 9,038 36,007 23,014Life Sciences3,020 3,026 8,291 7,378Healthcare455 (522) 936 (3,423)Physician3,207 2,194 6,269 3,961 $36,496 $13,736 $66,097 $30,930_____ (1) Apex operating income includes acquisition relate